(-)-Fusidic acid

(-)-fusidic acid is a lipid of Prenol Lipids (PR) class. (-)-fusidic acid is associated with abnormalities such as Bacterial Endocarditis and Pyoderma.

Cross Reference

Introduction

To understand associated biological information of (-)-Fusidic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (-)-Fusidic acid?

(-)-Fusidic acid is suspected in Bacterial Endocarditis, Pyoderma and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (-)-Fusidic acid

MeSH term MeSH ID Detail
Wound Infection D014946 12 associated lipids
Rosacea D012393 13 associated lipids
Community-Acquired Infections D017714 8 associated lipids
Skin Diseases, Bacterial D017192 8 associated lipids
Total 4

PubChem Associated disorders and diseases

What pathways are associated with (-)-Fusidic acid

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (-)-Fusidic acid?

There are no associated biomedical information in the current reference collection.

What functions are associated with (-)-Fusidic acid?

There are no associated biomedical information in the current reference collection.

What lipids are associated with (-)-Fusidic acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with (-)-Fusidic acid?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with (-)-Fusidic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (-)-Fusidic acid

Download all related citations
Per page 10 20 50 100 | Total 1496
Authors Title Published Journal PubMed Link
An Q et al. High Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis. 2017 Chin. Med. J. pmid:28685715
Argemi X et al. VISLISI trial, a prospective clinical study allowing identification of a new metalloprotease and putative virulence factor from Staphylococcus lugdunensis. 2017 Clin. Microbiol. Infect. pmid:28017792
Patot S et al. The TIR Homologue Lies near Resistance Genes in Staphylococcus aureus, Coupling Modulation of Virulence and Antimicrobial Susceptibility. 2017 PLoS Pathog. pmid:28060920
Xiao JH et al. Synergistic antitumor efficacy of antibacterial helvolic acid from Cordyceps taii and cyclophosphamide in a tumor mouse model. 2017 Exp. Biol. Med. (Maywood) pmid:27604096
Bessa GR et al. Staphylococcus aureus resistance to topical antimicrobials in atopic dermatitis. 2016 Sep-Oct An Bras Dermatol pmid:27828633
Fan W et al. An unusual case of folliculitis spinulosa decalvans. 2016 Cutis pmid:27814407
Eng H et al. The Antimicrobial Agent Fusidic Acid Inhibits Organic Anion Transporting Polypeptide-Mediated Hepatic Clearance and May Potentiate Statin-Induced Myopathy. 2016 Drug Metab. Dispos. pmid:26888941
Zhu M et al. Real time determination of bacterial in vivo ribosome translation elongation speed based on LacZα complementation system. 2016 Nucleic Acids Res. pmid:27903884
Baker KR et al. A High-Throughput Approach To Identify Compounds That Impair Envelope Integrity in Escherichia coli. 2016 Antimicrob. Agents Chemother. pmid:27458225
Gupta A et al. Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration. 2016 Antimicrob. Agents Chemother. pmid:27458210
May Zin WW et al. New Cyclotetrapeptides and a New Diketopiperzine Derivative from the Marine Sponge-Associated Fungus Neosartorya glabra KUFA 0702. 2016 Mar Drugs pmid:27447650
Knippenberg B et al. Validation and Application of a Dried Blood Spot Assay for Biofilm-Active Antibiotics Commonly Used for Treatment of Prosthetic Implant Infections. 2016 Antimicrob. Agents Chemother. pmid:27270283
Wood ME et al. Methicillin-resistant Staphylococcus aureus acquisition in healthcare workers with cystic fibrosis: a retrospective cross-sectional study. 2016 BMC Pulm Med pmid:27170040
Chen HJ et al. Distribution of Staphylococcal Cassette Chromosome (SCC) mec Element Types in Fusidic Acid-Resistant Staphylococcus epidermidis and Identification of a Novel SCC7684 Element. 2016 Antimicrob. Agents Chemother. pmid:27161629
Hittalmani S et al. De novo genome assembly and annotation of rice sheath rot fungus Sarocladium oryzae reveals genes involved in Helvolic acid and Cerulenin biosynthesis pathways. 2016 BMC Genomics pmid:27036298
Farrell DJ et al. Activity of Fusidic Acid Tested against Staphylococci Isolated from Patients in U.S. Medical Centers in 2014. 2016 Antimicrob. Agents Chemother. pmid:27021326
Borg A et al. Mechanism of fusidic acid inhibition of RRF- and EF-G-dependent splitting of the bacterial post-termination ribosome. 2016 Nucleic Acids Res. pmid:27001509
Thangamani S et al. Repurposing auranofin for the treatment of cutaneous staphylococcal infections. 2016 Int. J. Antimicrob. Agents pmid:26895605
Baines SL et al. Rapid Emergence and Evolution of Staphylococcus aureus Clones Harboring fusC-Containing Staphylococcal Cassette Chromosome Elements. 2016 Antimicrob. Agents Chemother. pmid:26856837
Tomlinson JH et al. A target-protection mechanism of antibiotic resistance at atomic resolution: insights into FusB-type fusidic acid resistance. 2016 Sci Rep pmid:26781961
Baek YS et al. Antimicrobial resistance of Staphylococcus aureus isolated from skin infections and its implications in various clinical conditions in Korea. 2016 Int. J. Dermatol. pmid:26892888
Precit MR et al. Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus. 2016 Antimicrob. Agents Chemother. pmid:26729501
Kinoshita H et al. Cryptic antifungal compounds active by synergism with polyene antibiotics. 2016 J. Biosci. Bioeng. pmid:26323525
Fan B et al. Activity of Colistin in Combination with Meropenem, Tigecycline, Fosfomycin, Fusidic Acid, Rifampin or Sulbactam against Extensively Drug-Resistant Acinetobacter baumannii in a Murine Thigh-Infection Model. 2016 PLoS ONE pmid:27315107
Leite FR et al. Use of Fusidic Acid for Desquamative Gingivitis Treatment: 1-Year Follow-Up. 2015 Jul-Aug Braz Dent J pmid:26312984
Gurel MS et al. Comparison of the effects of topical fusidic acid and rifamycin on wound healing in rats. 2015 Int Wound J pmid:23489386
Hung WC et al. Skin Commensal Staphylococci May Act as Reservoir for Fusidic Acid Resistance Genes. 2015 PLoS ONE pmid:26581090
Sandmeyer LS et al. Diagnostic Ophthalmology. Corneal lesion in a cat. 2015 Can. Vet. J. pmid:26538679
Yu F et al. Dissemination of fusidic acid resistance among Staphylococcus aureus clinical isolates. 2015 BMC Microbiol. pmid:26463589
Hamad T et al. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections, with focus on doxycycline. 2015 APMIS pmid:26547372
Phee LM et al. Colistin and Fusidic Acid, a Novel Potent Synergistic Combination for Treatment of Multidrug-Resistant Acinetobacter baumannii Infections. 2015 Antimicrob. Agents Chemother. pmid:25987639
Roubelakis A et al. Coronary artery rupture caused by stent infection: a rare complication. 2015 Circulation pmid:25847982
Zhang S et al. Three new fusidic acid derivatives and their antibacterial activity. 2015 Bioorg. Med. Chem. Lett. pmid:25824664
Damali Amiri N and Wijenaike N Flucloxacillin and fusidic acid-associated neutropenia in a patient with periaortic abscess: rare side effects of commonly used antibiotics. 2015 BMJ Case Rep pmid:25809430
Ellington MJ et al. Emergent and evolving antimicrobial resistance cassettes in community-associated fusidic acid and meticillin-resistant Staphylococcus aureus. 2015 Int. J. Antimicrob. Agents pmid:25769787
Clark SM et al. Susceptibility in vitro of canine methicillin-resistant and -susceptible staphylococcal isolates to fusidic acid, chlorhexidine and miconazole: opportunities for topical therapy of canine superficial pyoderma. 2015 J. Antimicrob. Chemother. pmid:25749003
Hall H et al. Eradication of respiratory tract MRSA at a large adult cystic fibrosis centre. 2015 Respir Med pmid:25683032
Jayanetti DR et al. Hypocoprins A-C: new sesquiterpenoids from the coprophilous fungus Hypocopra rostrata. 2015 J. Nat. Prod. pmid:25549014
Borg A et al. Fusidic acid targets elongation factor G in several stages of translocation on the bacterial ribosome. 2015 J. Biol. Chem. pmid:25451927
Frikh R and Boui M [Albinism and folliculitis keloidalis nuchae in a man of African descent]. 2015 Ann Dermatol Venereol pmid:26362134
Gustafsson F et al. A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans. 2014 Toxicol. Sci. pmid:24085192
Shim J et al. Clinical inquiry: what is the best treatment for impetigo ? 2014 J Fam Pract pmid:25061625
Champion EA et al. Antimicrobial susceptibility and molecular typing of MRSA in cystic fibrosis. 2014 Pediatr. Pulmonol. pmid:23765686
Suematsu T et al. Arabidopsis thaliana mitochondrial EF-G1 functions in two different translation steps. 2014 J. Biochem. pmid:24272752
Lin YT et al. A novel staphylococcal cassette chromosomal element, SCCfusC, carrying fusC and speG in fusidic acid-resistant methicillin-resistant Staphylococcus aureus. 2014 Antimicrob. Agents Chemother. pmid:24277045
Lim KT et al. Mutations in rpoB and fusA cause resistance to rifampicin and fusidic acid in methicillin-resistant Staphylococcus aureus strains from a tertiary hospital in Malaysia. 2014 Trans. R. Soc. Trop. Med. Hyg. pmid:24336696
O'Keeffe G et al. RNA-seq reveals the pan-transcriptomic impact of attenuating the gliotoxin self-protection mechanism in Aspergillus fumigatus. 2014 BMC Genomics pmid:25311525
Rørtveit S et al. The decline of the impetigo epidemic caused by the epidemic European fusidic acid-resistant impetigo clone: an 11.5-year population-based incidence study from a community in Western Norway. 2014 Scand. J. Infect. Dis. pmid:25229166
Gupta A et al. The effect of fusidic acid on Plasmodium falciparum elongation factor G (EF-G). 2013 Nov-Dec Mol. Biochem. Parasitol. pmid:24211494
Lynch M et al. Bullae of the hands, feet, and perioral area in a 3-month-old infant. Bullous pemphigoid. 2013 Jan-Feb Pediatr Dermatol pmid:23316718
Morgan RE et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. 2013 Toxicol. Sci. pmid:23956101
Pedersen JM et al. Early identification of clinically relevant drug interactions with the human bile salt export pump (BSEP/ABCB11). 2013 Toxicol. Sci. pmid:24014644
Kang D et al. Culture condition-dependent metabolite profiling of Aspergillus fumigatus with antifungal activity. 2013 Fungal Biol pmid:23537878
Salama AA et al. Evaluation of in vitro and in vivo inhibitory effects of fusidic acid on Babesia and Theileria parasites. 2013 Vet. Parasitol. pmid:22985928
Avci O et al. A comparison between the effectiveness of erythromycin, single-dose clarithromycin and topical fusidic acid in the treatment of erythrasma. 2013 J Dermatolog Treat pmid:21923567
Ashraf MO and Asumu T Bilateral knee replacements for treatment of acute septic arthritis in both knees. 2013 Eur J Orthop Surg Traumatol pmid:23412206
Cox G et al. Mutagenesis mapping of the protein-protein interaction underlying FusB-type fusidic acid resistance. 2013 Antimicrob. Agents Chemother. pmid:23836182
Vingsbo Lundberg C and Frimodt-Møller N Efficacy of topical and systemic antibiotic treatment of meticillin-resistant Staphylococcus aureus in a murine superficial skin wound infection model. 2013 Int. J. Antimicrob. Agents pmid:23837927
Zhou J et al. Crystal structures of EF-G-ribosome complexes trapped in intermediate states of translocation. 2013 Science pmid:23812722
Sahm DF et al. In vitro activity of CEM-102 (fusidic acid) against prevalent clones and resistant phenotypes of Staphylococcus aureus. 2013 Antimicrob. Agents Chemother. pmid:23774441
Grillo E et al. Successful treatment of venous malformation located on glans penis with dual-wavelength 595- and 1064-nm laser system. 2013 J Cosmet Laser Ther pmid:23688237
Gilchrist SE et al. Fusidic acid and rifampicin co-loaded PLGA nanofibers for the prevention of orthopedic implant associated infections. 2013 J Control Release pmid:23639451
Huang J et al. Prevalence of fusB in Staphylococcus aureus clinical isolates. 2013 J. Med. Microbiol. pmid:23639984
Molina-Cabrillana J et al. [Antibiotic ointments and methicillin-resistant Staphylococcus aureus with a reservoir in a healthcare worker in a tertiary hospital]. 2013 Enferm. Infecc. Microbiol. Clin. pmid:23218870
Gavrilova M et al. Eruption in a patient with Crohn disease. 2013 JAMA Dermatol pmid:23324767
Bulitta JB et al. Population pharmacokinetics of fusidic acid: rationale for front-loaded dosing regimens due to autoinhibition of clearance. 2013 Antimicrob. Agents Chemother. pmid:23147726
Gabignon C et al. [Rhabdomyolysis following the coprescription of atorvastatin and fusidic acid]. 2013 Rev Med Interne pmid:23102978
Peel TN et al. Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy. 2013 Antimicrob. Agents Chemother. pmid:23114758
Kurata S et al. Possible steps of complete disassembly of post-termination complex by yeast eEF3 deduced from inhibition by translocation inhibitors. 2013 Nucleic Acids Res. pmid:23087377
Pimenta P et al. Canine ocular thelaziosis caused by Thelazia callipaeda in Portugal. 2013 Vet Ophthalmol pmid:23067512
Cowan R et al. A timely reminder about the concomitant use of fusidic acid with statins. 2013 Clin. Infect. Dis. pmid:23588554
Zhao M et al. Protostane and fusidane triterpenes: a mini-review. 2013 Molecules pmid:23563857
Chen HJ et al. New structure of phage-related islands carrying fusB and a virulence gene in fusidic acid-resistant Staphylococcus epidermidis. 2013 Antimicrob. Agents Chemother. pmid:23979742
Payne AJ et al. Fusidic acid is an effective treatment against Toxoplasma gondii and Listeria monocytogenes in vitro, but not in mice. 2013 Parasitol. Res. pmid:23949312
Shallcross LJ et al. Use of primary care data for detecting impetigo trends, United kingdom, 1995-2010. 2013 Emerging Infect. Dis. pmid:24047615
Buhrow L et al. Computational prediction and in vitro analysis of potential physiological ligands of the bile acid binding site in cytochrome c oxidase. 2013 Biochemistry pmid:24073649
Trenin AS [Microbial test-system for screening of inhibitors of sterol biosynthesis]. 2013 Antibiot. Khimioter. pmid:24640144
Palmer SO et al. Two homologous EF-G proteins from Pseudomonas aeruginosa exhibit distinct functions. 2013 PLoS ONE pmid:24260360
Selmer M et al. Ribosome engineering to promote new crystal forms. 2012 Acta Crystallogr. D Biol. Crystallogr. pmid:22525755
Wang JL et al. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus. 2012 Int. J. Antimicrob. Agents pmid:22612900
Elazhari M et al. Characterization of fusidic acid-resistant Staphylococcus aureus isolates in the community of Casablanca (Morocco). 2012 Int. J. Med. Microbiol. pmid:22197537
Hon KL et al. Combined antibiotic/corticosteroid cream in the empirical treatment of moderate to severe eczema: friend or foe? 2012 J Drugs Dermatol pmid:22777230
Zhao J et al. Preparative separation of helvolic acid from the endophytic fungus Pichia guilliermondii Ppf9 by high-speed counter-current chromatography. 2012 World J. Microbiol. Biotechnol. pmid:22805802
Venugopal AA and Johnson S Current state of Clostridium difficile treatment options. 2012 Clin. Infect. Dis. pmid:22752868
Koripella RK et al. Mechanism of elongation factor-G-mediated fusidic acid resistance and fitness compensation in Staphylococcus aureus. 2012 J. Biol. Chem. pmid:22767604
Lama A et al. Response of methicillin-resistant Staphylococcus aureus to amicoumacin A. 2012 PLoS ONE pmid:22479511
Gilchrist SE et al. Phase separation behavior of fusidic acid and rifampicin in PLGA microspheres. 2012 Mol. Pharm. pmid:22482935
Uaboonkul T et al. A randomized control study of the prevention of hyperpigmentation post Q-switched Nd:YAG laser treatment of Hori nevus using topical fucidic acid plus betamethasone valerate cream versus fucidic acid cream. 2012 J Cosmet Laser Ther pmid:22471899
Guo X et al. Structure and function of FusB: an elongation factor G-binding fusidic acid resistance protein active in ribosomal translocation and recycling. 2012 Open Biol pmid:22645663
D'Lima L et al. No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coli. 2012 Antimicrob. Agents Chemother. pmid:22354299
Shore AC et al. DNA microarray profiling of a diverse collection of nosocomial methicillin-resistant staphylococcus aureus isolates assigns the majority to the correct sequence type and staphylococcal cassette chromosome mec (SCCmec) type and results in the subsequent identification and characterization of novel SCCmec-SCCM1 composite islands. 2012 Antimicrob. Agents Chemother. pmid:22869569
Lambert T Antibiotics that affect the ribosome. 2012 Rev. - Off. Int. Epizoot. pmid:22849268
Westendorp C and van der Meijden W [A persistent 'insect bite']. 2012 Ned Tijdschr Geneeskd pmid:23191976
Crepinsek MA et al. Interventions for preventing mastitis after childbirth. 2012 Cochrane Database Syst Rev pmid:23076933
Gilchrist SE et al. The solid-state characterization of fusidic acid. 2012 Int J Pharm pmid:22100514
Nomura Y et al. ppGpp inhibits peptide elongation cycle of chloroplast translation system in vitro. 2012 Plant Mol. Biol. pmid:22108865
Liu Y et al. Susceptibility to and resistance determinants of fusidic acid in Staphylococcus aureus isolated from Chinese children with skin and soft tissue infections. 2012 FEMS Immunol. Med. Microbiol. pmid:22066960
Said SS et al. Bioburden-responsive antimicrobial PLGA ultrafine fibers for wound healing. 2012 Eur J Pharm Biopharm pmid:21924354
Rijnders MI et al. Spread of the epidemic European fusidic acid-resistant impetigo clone (EEFIC) in general practice patients in the south of The Netherlands. 2012 J. Antimicrob. Chemother. pmid:22290345
Koning S et al. Interventions for impetigo. 2012 Cochrane Database Syst Rev pmid:22258953